Follow
Christopher A. Klebanoff, M.D.
Christopher A. Klebanoff, M.D.
Verified email at mskcc.org
Title
Cited by
Cited by
Year
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
RM Samstein, CH Lee, AN Shoushtari, MD Hellmann, R Shen, ...
Nature genetics 51 (2), 202-206, 2019
29852019
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni, SE Finkelstein, CA Klebanoff, PA Antony, DC Palmer, ...
The Journal of experimental medicine 202 (7), 907-912, 2005
12022005
Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells
CA Klebanoff, L Gattinoni, P Torabi-Parizi, K Kerstann, AR Cardones, ...
Proceedings of the national academy of sciences 102 (27), 9571-9576, 2005
11712005
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni, CA Klebanoff, DC Palmer, C Wrzesinski, K Kerstann, Z Yu, ...
The Journal of clinical investigation 115 (6), 1616-1626, 2005
11592005
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
WW Overwijk, MR Theoret, SE Finkelstein, DR Surman, LA De Jong, ...
The Journal of experimental medicine 198 (4), 569-580, 2003
11182003
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells
PA Antony, CA Piccirillo, A Akpinarli, SE Finkelstein, PJ Speiss, ...
The Journal of Immunology 174 (5), 2591-2601, 2005
9452005
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function
M Sukumar, J Liu, Y Ji, M Subramanian, JG Crompton, Z Yu, ...
The Journal of clinical investigation 123 (10), 4479-4488, 2013
8822013
TOX is a critical regulator of tumour-specific T cell differentiation
AC Scott, F DŁndar, P Zumbo, SS Chandran, CA Klebanoff, M Shakiba, ...
Nature 571 (7764), 270-274, 2019
7632019
IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells
CA Klebanoff, SE Finkelstein, DR Surman, MK Lichtman, L Gattinoni, ...
Proceedings of the National Academy of Sciences 101 (7), 1969-1974, 2004
6702004
Paths to stemness: building the ultimate antitumour T cell
L Gattinoni, CA Klebanoff, NP Restifo
Nature Reviews Cancer 12 (10), 671-684, 2012
6512012
CD8+ T‐cell memory in tumor immunology and immunotherapy
CA Klebanoff, L Gattinoni, NP Restifo
Immunological reviews 211 (1), 214-224, 2006
6352006
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy
CA Klebanoff, HT Khong, PA Antony, DC Palmer, NP Restifo
Trends in immunology 26 (2), 111-117, 2005
5492005
Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels
JN Kochenderfer, RPT Somerville, T Lu, V Shi, A Bot, J Rossi, A Xue, ...
Journal of clinical oncology 35 (16), 1803, 2017
5382017
Ionic immune suppression within the tumour microenvironment limits T cell effector function
R Eil, SK Vodnala, D Clever, CA Klebanoff, M Sukumar, JH Pan, ...
Nature 537 (7621), 539-543, 2016
5252016
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
CS Hinrichs, R Spolski, CM Paulos, L Gattinoni, KW Kerstann, DC Palmer, ...
Blood, The Journal of the American Society of Hematology 111 (11), 5326-5333, 2008
5052008
Th17 cells are long lived and retain a stem cell-like molecular signature
P Muranski, ZA Borman, SP Kerkar, CA Klebanoff, Y Ji, L Sanchez-Perez, ...
Immunity 35 (6), 972-985, 2011
4832011
BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis
R Roychoudhuri, K Hirahara, K Mousavi, D Clever, CA Klebanoff, ...
Nature 498 (7455), 506-510, 2013
4112013
Randomized, prospective evaluation comparing intensity of lymphodepletion before adoptive transfer of tumor-infiltrating lymphocytes for patients with metastatic melanoma
SL Goff, ME Dudley, DE Citrin, RP Somerville, JR Wunderlich, ...
Journal of Clinical Oncology 34 (20), 2389, 2016
3952016
Therapeutic cancer vaccines: are we there yet?
CA Klebanoff, N Acquavella, Z Yu, NP Restifo
Immunological reviews 239 (1), 27-44, 2011
3772011
T cell stemness and dysfunction in tumors are triggered by a common mechanism
SK Vodnala, R Eil, RJ Kishton, M Sukumar, TN Yamamoto, NH Ha, ...
Science 363 (6434), eaau0135, 2019
3752019
The system can't perform the operation now. Try again later.
Articles 1–20